Search clinical trials for: von Willebrand factor (Recombinant)
Total 3136 results
-
University of VirginiaNot yet recruiting
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Australia, Taiwan, Czechia, Turkey, Ukraine, Netherlands, Italy, United Kingdom, Austria, Germany, Russian Federation
-
TakedaAvailableVon Willebrand Disease (VWD)
-
National Center for Research Resources (NCRR)University of North CarolinaCompletedVon Willebrand's Disease
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingVon Willebrand DiseaseUnited States, Belgium, Spain, Italy, Turkey, Germany, Austria, France, Czechia, Russian Federation, Ukraine, United Kingdom, Netherlands
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Germany, United Kingdom, Italy, Austria, Canada
-
TakedaBaxalta Innovations GmbH, now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Italy, Turkey, Germany, Russian Federation, Netherlands, France, Canada
-
TakedaNot yet recruitingVon Willebrand Disease (VWD)
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseNetherlands, Spain, United States, Belgium, Australia, United Kingdom, Austria, Italy, Bulgaria, Japan, Poland, Germany, India, Canada, Russian Federation, Sweden
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlActive, not recruitingType 3 Von Willebrand's DiseaseFinland, France, Germany, Hungary, Iran, Islamic Republic of, Italy, Netherlands, Spain, Sweden, United Kingdom
-
OctapharmaTerminated
-
Assiut UniversityNot yet recruitingAngiodysplasia | Hematological Disease
-
Tirol Kiniken GmbHLFB BIOMEDICAMENTSUnknown
-
Grifols Therapeutics LLCGrifols Biologicals, LLCTerminatedHemophilia A, CongenitalUnited States, Spain, Italy, India, Canada, Russian Federation
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Hungary, Russian Federation, Ukraine, Belarus, Bulgaria
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Belarus, Bulgaria, Hungary, Russian Federation, Ukraine
-
OctapharmaCompletedSevere Hemophilia ABulgaria, Poland, Hungary, Romania, Russian Federation
-
CSL BehringParexelCompletedVon Willebrand DiseaseBulgaria, Poland, Russian Federation, Ukraine
-
Hospitales Universitarios Virgen del RocíoCompletedCoagulation Disorder | CarcinomatosisSpain
-
Margaret RagniNational Heart, Lung, and Blood Institute (NHLBI); Duke University; University...TerminatedVon Willebrand DiseasesUnited States
-
Unity Health TorontoNot yet recruiting
-
Assiut UniversityUnknownVon Willebrand Disease, Type 1
-
CSL BehringParexelCompletedHemophilia ABulgaria, Poland, Russian Federation, Macedonia, The Former Yugoslav Republic of
-
Assiut UniversityUnknownInflammatory Bowel Diseases | Von Willebrand DiseasesEgypt
-
Nicoletta C MachinRecruitingPostpartum Hemorrhage | Von Willebrand DiseasesUnited States
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompleted
-
Baxalta now part of ShireCompleted
-
Sohag UniversityNot yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Baxalta now part of ShireTakedaCompleted
-
Aljazeera HospitalCompleted
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumTerminatedHemophilia A | Hemophilia BUnited States
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia BSweden, United States, France, Italy, Russian Federation, United Kingdom, Germany, China, Poland, Japan, Australia, Brazil, Canada, India, South Africa, Hong Kong, Belgium
-
The Hospital for Sick ChildrenCompleted
-
Novo Nordisk A/SEnrolling by invitationCongenital Bleeding Disorder | Congenital FXIII DeficiencyJapan
-
United States Army Institute of Surgical ResearchCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyFrance, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Baxalta now part of ShireCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencySpain, United States, Canada, Italy, United Kingdom, Hungary
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom, Israel, United States
-
Baxalta now part of ShireCompletedHemophilia A | Hemophilia BUnited States
-
BayerCompletedHemophilia A | Blood Coagulation DisordersSpain, Taiwan, Austria, United States, Germany, Thailand, United Kingdom, Italy, Turkey, Croatia, Serbia, Poland, Israel, Sweden, Indonesia, Argentina, Norway, South Africa, India, Hong Kong, Denmark, Pakistan
-
Universiti Sains MalaysiaCompletedMassive Hemorrhage | Massive Blood Loss | Massive Blood Transfusion; ThrombocytopeniaMalaysia
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderUnited States, Canada
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Acquired Bleeding Disorder | Acquired Haemophilia | Congenital FVII Deficiency | Glanzmann's DiseaseFrance
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageSpain, Sweden, Singapore, Norway, Italy, Switzerland, Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Netherlands, United Kingdom
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding DisorderUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BFrance, Israel, Germany